196 related articles for article (PubMed ID: 28639328)
1. Immunogenicity of protein aggregates of a monoclonal antibody generated by forced shaking stress with siliconized and nonsiliconized syringes in BALB/c mice.
Uchino T; Miyazaki Y; Yamazaki T; Kagawa Y
J Pharm Pharmacol; 2017 Oct; 69(10):1341-1351. PubMed ID: 28639328
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of L-Asparaginase in Siliconized Syringes with Shaking and Headspace Air Induces Protein Aggregation.
Uchino T; Miyazaki Y; Ohkawa T; Yamazaki T; Yanagihara Y; Yoshimori T; Komatsu M; Suzuki H; Kagawa Y
Chem Pharm Bull (Tokyo); 2015; 63(10):770-9. PubMed ID: 26423033
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effect of syringe surfaces on protein formulations.
Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.
Bai S; Landsman P; Spencer A; DeCollibus D; Vega F; Temel DB; Houde D; Henderson O; Brader ML
J Pharm Sci; 2016 Jan; 105(1):50-63. PubMed ID: 26852839
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range.
Shah M; Rattray Z; Day K; Uddin S; Curtis R; van der Walle CF; Pluen A
Int J Pharm; 2017 Mar; 519(1-2):58-66. PubMed ID: 28089934
[TBL] [Abstract][Full Text] [Related]
6. Protein aggregation and particle formation in prefilled glass syringes.
Gerhardt A; Mcgraw NR; Schwartz DK; Bee JS; Carpenter JF; Randolph TW
J Pharm Sci; 2014 Jun; 103(6):1601-12. PubMed ID: 24729310
[TBL] [Abstract][Full Text] [Related]
7. Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies.
Rane SS; Dearman RJ; Kimber I; Uddin S; Bishop S; Shah M; Podmore A; Pluen A; Derrick JP
Pharm Res; 2019 Feb; 36(4):51. PubMed ID: 30771015
[TBL] [Abstract][Full Text] [Related]
8. Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.
Gerhardt A; Mcumber AC; Nguyen BH; Lewus R; Schwartz DK; Carpenter JF; Randolph TW
J Pharm Sci; 2015 Dec; 104(12):4056-4064. PubMed ID: 26413998
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of Protein Stability in Prefillable Syringes Made of Glass and Plastic.
Waxman L; Vilivalam VD
PDA J Pharm Sci Technol; 2017; 71(6):462-477. PubMed ID: 28819049
[TBL] [Abstract][Full Text] [Related]
10. IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers.
Basu P; Krishnan S; Thirumangalathu R; Randolph TW; Carpenter JF
J Pharm Sci; 2013 Mar; 102(3):852-65. PubMed ID: 23280943
[TBL] [Abstract][Full Text] [Related]
11. Colloidal Instability Fosters Agglomeration of Subvisible Particles Created by Rupture of Gels of a Monoclonal Antibody Formed at Silicone Oil-Water Interfaces.
Mehta SB; Carpenter JF; Randolph TW
J Pharm Sci; 2016 Aug; 105(8):2338-48. PubMed ID: 27422087
[TBL] [Abstract][Full Text] [Related]
12. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
[TBL] [Abstract][Full Text] [Related]
13. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
[TBL] [Abstract][Full Text] [Related]
14. Methods To Determine the Silicone Oil Layer Thickness in Sprayed-On Siliconized Syringes.
Loosli V; Germershaus O; Steinberg H; Dreher S; Grauschopf U; Funke S
PDA J Pharm Sci Technol; 2018; 72(3):278-297. PubMed ID: 29343617
[TBL] [Abstract][Full Text] [Related]
15. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes.
Gerhardt A; Nguyen BH; Lewus R; Carpenter JF; Randolph TW
J Pharm Sci; 2015 May; 104(5):1601-9. PubMed ID: 25740412
[TBL] [Abstract][Full Text] [Related]
16. Aggregation and Particle Formation of Therapeutic Proteins in Contact With a Novel Fluoropolymer Surface Versus Siliconized Surfaces: Effects of Agitation in Vials and in Prefilled Syringes.
Teska BM; Brake JM; Tronto GS; Carpenter JF
J Pharm Sci; 2016 Jul; 105(7):2053-65. PubMed ID: 27233685
[TBL] [Abstract][Full Text] [Related]
17. Can Cross-Linked Siliconized PFS Come to the Rescue of the Biologics Drug Product?
Thakare V; Schmidt T; Rupprechter O; Leibold J; Stemmer S; Mischo A; Bhattacharjee D; Prazeller P
J Pharm Sci; 2020 Nov; 109(11):3340-3351. PubMed ID: 32871152
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
[TBL] [Abstract][Full Text] [Related]
19. An Assessment of the Ability of Submicron- and Micron-Size Silicone Oil Droplets in Dropped Prefillable Syringes to Invoke Early- and Late-Stage Immune Responses.
Krayukhina E; Yokoyama M; Hayashihara KK; Maruno T; Noda M; Watanabe H; Uchihashi T; Uchiyama S
J Pharm Sci; 2019 Jul; 108(7):2278-2287. PubMed ID: 30790580
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses in mice to particles formed from adsorption of a murine monoclonal antibody onto glass microparticles.
Shomali M; Freitag A; Engert J; Siedler M; Kaymakcalan Z; Winter G; Carpenter JF; Randolph TW
J Pharm Sci; 2014 Jan; 103(1):78-89. PubMed ID: 24227137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
